Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
/in Brain Tumors in Children, Dendritic Cells, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2022-08-24 / Pharmaceutics 2022 Aug;14(9)Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
/in Dendritic Cells, Glioblastoma, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2022-01-19 / Genes Immun 2022 02;23(1):1-11Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
/in Dendritic Cells, Immunogenic Cell Death, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2020-03-01 / J Immunother Cancer 2020 03;8(1)Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2020-02-26 / J Cell Mol Med 2020 04;24(7):4286-4297STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
/in Immunogenic Cell Death, International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2019-05-29 / Front Oncol 2019;9:436Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2018-08-01 / Am J Cancer Res 2018;8(8):1514-1527Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
/in Dendritic Cells, Glioblastoma, Immunogenic Cell Death, International Publications, Prostate Cancer /von 2016-03-02 / Sci Transl Med 2016 Mar;8(328):328ra27Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
/in Glioblastoma, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2014-09-19 / Int J Cancer 2015 Mar;136(5):E313-25IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
- Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
- Immunotherapy in breast cancer: an overview of current strategies and perspectives